DS-8201a
Phase 2Completed 0 watching 0 views this week⚡ Active
52
Development Stage
✓
Pre-clinical✓
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Breast Tumors
Conditions
Breast Tumors
Trial Timeline
Oct 21, 2019 → Dec 26, 2024
NCT ID
NCT04132960About DS-8201a
DS-8201a is a phase 2 stage product being developed by Daiichi Sankyo for Breast Tumors. The current trial status is completed. This product is registered under clinical trial identifier NCT04132960. Target conditions include Breast Tumors.
Hype Score Breakdown
Clinical
17
Activity
12
Company
10
Novelty
5
Community
5
Clinical Trials (5)
| NCT ID | Phase | Status |
|---|---|---|
| NCT04132960 | Phase 2 | Completed |
| NCT03368196 | Phase 1 | Completed |
| NCT03384940 | Phase 2 | Completed |
| NCT03366428 | Phase 1 | Completed |
| NCT03248492 | Phase 2 | Terminated |
Competing Products
20 competing products in Breast Tumors